A study of dydrogesterone use in women with threatened miscarriage at the University of Ilorin Teaching Hospital

Pregnancy Outcome Following The Use of Dydrogesterone In Threatened Miscarriage At The University Of Ilorin Teaching Hospital: A Single-blind, Placebo Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202602897060718

Enrollment

Registered

2026-02-05

Start date

2026-02-09

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Threatened Miscarriage

Interventions

Dydrogesterone

Matching Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women between ages 18-40 years 2. Mild to moderate vaginal bleeding 3. Intrauterine gestation confirmed by pelvic ultrasound for appropriate gestational age 4. Gestational age = 20 weeks 5. Absence of fever or known medical conditions

Exclusion criteria

Exclusion criteria: 1. History of recurrent miscarriage 2. Prior use of progestogen in current pregnancy 3. History of luteal phase support following assisted reproduction 4. Presence of fever or known medical conditions

Design outcomes

Primary

Measure	Time frame
The proportion of participants with pregnancy continuation to 28 completed weeks’ gestation and beyond.	—

Secondary

Measure	Time frame
The proportion of participants with miscarriages (complete and incomplete).;Gestational age at the time of bleeding cessation for those that had successful treatment;Occurrence of side effects	—

Countries

Nigeria

Contacts

Public ContactOluwasegun Aboyeji

Public enquiries

teesurge@yahoo.com+2347038996236

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026